60 Degrees Pharmaceuticals, Inc. (SXTPW) stock
SXTPWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SXTP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 8/3033% below fair value
$0.03−0.00 (-0.38%)
Close on Oct 30, 2026Market cap $3.31MP/E –Yield –
60 Degrees Pharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
60 Degrees Pharmaceuticals's total debt was $2.00K at Jun 30, 2026. For fiscal 2025 it was $152.78K, down 2.0% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $152.78K | -2.0% |
| FY2024 | Dec 31, 2024 | $155.89K | +1677.1% |
| FY2023 | Dec 31, 2023 | $8.77K | -99.9% |
| FY2022 | Dec 31, 2022 | $16.86M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.00K | -77.2% |
| Q1 FY2026 | Mar 31, 2026 | $8.77K | 0.0% |
| Q4 FY2025 | Dec 31, 2025 | $152.78K | -2.0% |
| Q3 FY2025 | Sep 30, 2025 | $8.77K | 0.0% |
| Q2 FY2025 | Jun 30, 2025 | $8.77K | 0.0% |
| Q1 FY2025 | Mar 31, 2025 | $8.77K | 0.0% |
| Q4 FY2024 | Dec 31, 2024 | $155.89K | +1677.1% |
| Q3 FY2024 | Sep 30, 2024 | $8.77K | -100.0% |
| Q2 FY2024 | Jun 30, 2024 | $8.77K | -95.6% |
| Q1 FY2024 | Mar 31, 2024 | $8.77K | -99.9% |
| Q4 FY2023 | Dec 31, 2023 | $8.77K | – |
| Q2 FY2023 | Jun 30, 2023 | $24.65M | – |
| Q1 FY2023 | Mar 31, 2023 | $200.00K | – |
| Q4 FY2022 | Dec 31, 2022 | $16.86M | – |